Search Results - "Oller Rodríguez, José Eloy"

P28 Drug-induced lupus: clinical and serological features in a tertiary hospital by Leal, Samuel, Álvarez, Iago Alcántara, Verdejo, Inmaculada Chalmeta, Charia, Hikmat, Navarro, Marta de la Rubia, Puig, Luis González, García, Elena Grau, Huaylla Quispe, Anderson Víctor, Cortés, José Ivorra, Cordellat, Isabel Martínez, Sánchez, Laura Mas, Muñoz Martínez, Pablo Francisco, Albuixech, Rosa Negueroles, Oller Rodríguez, José Eloy, Castro, Daniel Ramos, Bárcena, Carmen Riesco, Novés, Alba Torrat, Sugrañes, Ernesto Tovar, Bernabeu, Elvira Vicens, Mañes, Belén Villanueva, Olmos, Inés Cánovas, Herranz, Carmen Nájera, Román Ivorra, José Andrés

“…ObjectiveSeveral drugs have been implicated in the development of de novo systemic lupus erythematosus (SLE), unmasking of quiescent SLE or causing an…”
Get full text

P9 Increase of IL10 and INFA2 are associated to clinical activity in systemic lupus erythematous patients by García, Elena Grau, Álvarez, Iago Alcántara, Verdejo, Inmaculada Chalmeta, Charia, Hikmat, Navarro, Marta de la Rubia, Puig, Luis González, Huaylla Quispe, Anderson Víctor, Cortés, José Ivorra, Leal, Samuel, Cordellat, Isabel Martínez, Sánchez, Laura Mas, Muñoz Martínez, Pablo Francisco, Albuixech, Rosa Negueroles, Oller Rodríguez, José Eloy, Castro, Daniel Ramos, Bárcena, Carmen Riesco, Novés, Alba Torrat, Sugrañes, Ernesto Tovar, Bernabeu, Elvira Vicens, Mañes, Belén Villanueva, Olmos, Inés Cánovas, Herranz, Carmen Nájera, Urmeneta, Guillen Sada, Román Ivorra, José Andrés

“…ObjectiveWe aimed to analyze the association between inflammatory cytokine levels (IFN-a2, IFN-b, IFN-g, IL10 and BLyS) and disease activity for a 12 months of…”
Get full text

P149 Clinical worsening in non-adherent belimumab treatment in SLE by Navarro, Marta de la Rubia, García, Elena Grau, Monreal, Ma Jesús Cuellar, Álvarez, Iago Alcántara, Verdejo, Inmaculada Chalmeta, Charia, Hikmat, Puig, Luis González, Huaylla Quispe, Anderson Víctor, Cortés, José Ivorra, Leal, Samuel, Cordellat, Isabel Martínez, Sánchez, Laura Mas, Muñoz Martínez, Pablo Francisco, Albuixech, Rosa Negueroles, Oller Rodríguez, José Eloy, Castro, Daniel Ramos, Bárcena, Carmen Riesco, Novés, Alba Torrat, Sugrañes, Ernesto Tovar, Bernabeu, Elvira Vicens, Mañes, Belén Villanueva, Olmos, Inés Cánovas, Herranz, Carmen Nájera, Román Ivorra, José Andrés

“…ObjectiveThe objective is to analyze the association between therapeutic adherence and disease activity in SLE patients.MethodsAn observational, prospective…”
Get full text

P147 Neuropsychiatric manifestations and mental disorders, a complex spectrum of heterogeneous disease: a descriptive cohort study by González-Mazarío, Roxana, Fragío Gil, Jorge Juan, Cortés, José Ivorra, Grau-García, Elena, González-Puig, Luis, Ortiz Sanjuan, Francisco Miguel, Leal-Rodriguez, Samuel, Martínez-Cordellat, Isabel, Negueroles-Albuixech, Rosa, Oller-Rodríguez, José Eloy, De-la-Rubia-Navarro, Marta, Chalmeta-Verdejo, Inmaculada, Alcañiz-Escandell, Cristina, Pavez-Perales, Cristóbal, Vicens-Bernabeu, Elvira, Nájera-Herranz, Carmen, Cánovas-Olmos, Inés, Román-Ivorra, José Andrés

“…BackgroundNeuropsychiatric manifestations in patients with systemic lupus erythematosus (SLE), termed neuropsychiatric SLE (NPSLE), involve a wide variety of…”
Get full text

P180 Correlation between patient reported outcomes of health-related quality of life and clinical activity in systemic lupus erythematosus patients by Grau-García, Elena, Leal-Rodríguez, Samuel, Pávez-Perales, Cristóbal, Alcañiz-Escandell, Cristina, Cánovas-Olmos, Inés, Chalmeta-Verdejo, Inmaculada, De-la-Rubia-Navarro, Marta, Fragio-Gil, Jorge Juan, González-Mazarío, Roxana, González-Puig, Luis, Ivorra-Cortés, José, Martínez-Cordellat, Isabel, Nájera-Herranz, Carmen, Negueroles-Albuixech, Rosa, Oller-Rodríguez, José Eloy, Ortiz-Sanjuán, Francisco Miguel, Vicens-Bernabeu, Elvira, Hervás-Marín, Daniel, Román-Ivorra, José Andrés

“…Background/PurposePatient-Reported Outcomes (PROs) allow us to know how the disease could affect patients, and maybe could not be detected by clinical…”
Get full text

P167 Long term follow-up of lupus patients under antimalaric treatment: factors of drop-out by González-Mazarío, Roxana, Fragío Gil, Jorge Juan, Cortés, José Ivorra, Grau-García, Elena, González-Puig, Luis, Ortiz Sanjuan, Francisco Miguel, Leal-Rodriguez, Samuel, Martínez-Cordellat, Isabel, Negueroles-Albuixech, Rosa, Oller-Rodríguez, José Eloy, De-la-Rubia-Navarro, Marta, Chalmeta-Verdejo, Inmaculada, Alcañiz-Escandell, Cristina, Pavez-Perales, Cristóbal, Vicens-Bernabeu, Elvira, Nájera-Herranz, Carmen, Cánovas-Olmos, Inés, Román-Ivorra, José Andrés

“…BackgroundAntimalarials represent the cornerstone of SLE treatment, since its uses control clinical manifestations in many patients, prevents disease flare and…”
Get full text